Evidence map›Paper›PMID 36837810›Full record

ArticleMetabolites2023

Growth Hormone Alters Circulating Levels of Glycine and Hydroxyproline in Mice.

Jonathan A Young, Silvana Duran-Ortiz, Stephen Bell, Kevin Funk, Yuan Tian, Qing Liu, Andrew D Patterson, Edward O List, Darlene E Berryman, John J Kopchick

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Blood biomarkers and breed genetics of aging in pet dogs.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jonathan A YoungHeritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.ORCID 0000-0003-1770-1391
Silvana Duran-OrtizEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.
Stephen BellHeritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
Kevin FunkEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.
Yuan TianDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, State College, PA 16803, USA.ORCID 0000-0001-6174-3359
Qing LiuDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, State College, PA 16803, USA.
Andrew D PattersonDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, State College, PA 16803, USA.ORCID 0000-0003-2073-0070
Edward O ListEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.
Darlene E BerrymanHeritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.ORCID 0000-0003-4240-9229
John J KopchickHeritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
Biotechnology Institute · USPennsylvania State University · USOhio University · US

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
NIA NIH HHS R01 AG059779NIA NIH HHS R01AG059779
6 · The paper itself

Abstract

Growth hormone (GH) has established effects on protein metabolism, such as increasing protein synthesis and decreasing amino acid degradation, but its effects on circulating amino acid levels are less studied. To investigate this relationship, metabolomic analyses were used to measure amino acid concentrations in plasma and feces of mice with alterations to the GH axis, namely bovine GH transgenic (bGH; increased GH action) and GH receptor knockout (GHRKO; GH resistant) mice. To determine the effects of acute GH treatment, GH-injected GH knockout (GHKO) mice were used to measure serum glycine. Furthermore, liver gene expression of glycine metabolism genes was assessed in bGH, GHRKO, and GH-injected GHKO mice. bGH mice had significantly decreased plasma glycine and increased hydroxyproline in both sexes, while GHRKO mice had increased plasma glycine in both sexes and decreased hydroxyproline in males. Glycine synthesis gene expression was decreased in bGH mice (Shmt1 in females and Shmt2 in males) and increased in GHRKO mice (Shmt2 in males). Acute GH treatment of GHKO mice caused decreased liver Shmt1 and Shmt2 expression and decreased serum glycine. In conclusion, GH alters circulating glycine and hydroxyproline levels in opposing directions, with the glycine changes at least partially driven by decreased glycine synthesis.

Indexed as

amino acidsgrowth hormonemetabolomicstranscriptomics

Identifiers

PMID36837810
PMCPMC9959592
OpenAlexW4318476751

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.